| Objective measure | ||||||
---|---|---|---|---|---|---|---|
DAS28(3)-ESR (n = 531) | CDAI (n = 298) | ||||||
Total | Remission | No remission | Total | Remission | No remission | ||
Rheumatologists’ evaluation | Total | 531 (100.0%) | 163 (30.7%) | 368 (69.3%) | 298 (100.0%) | 44 (14.8%) | 254 (85.2%) |
Remission | 264 (49.7%) | Concordant – both remission 127 (23.9%) | Rheumatologist –negatively discordant 137 (25.8%) | 146 (49.0%) | Concordant – both remission 40 (13.4%) | Rheumatologist –negatively discordant 106 (35.6%) | |
No remission | 267 (50.3%) | Rheumatologist – positively discordant 36 (6.8%) | Concordant – both not remission 231 (43.5%) | 152 (51.0%) | Rheumatologist – positively discordant 4 (1.3%) | Concordant – both not remission 148 (49.7%) |